Radiotherapy of locally advanced pancreatic cancer

Abstract

Jin Linzhi, Wang Renben. Radiotherapy of locally advanced pancreatic cancer[J]. Journal of International Oncology, 2015, 42(1): 64-66.

［1］ Brunner TB, ScottBrown M. The role of radiotherapy in multimodal treatment of pancreatic carcinoma［J］. Radiat Oncol, 2010, 5: 64. ［2］ Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6 000 rads) radiation alone, moderate dose radiation (4 000 rads + 5fluorouracil), and high dose radiation + 5fluorouracil: the gastrointestinal tumor study group［J］. Cancer, 1981, 48(8): 1705-1710. ［3］ Cohen SJ, Dobelbower R Jr, Lipsitz S, et al. A randomized phase Ⅲ study of radiotherapy alone or with 5fluorouracil and mitomycinC in patients with locally advanced adenocarcinoma of the pancreas: eastern cooperative oncology group study E8282［J］. Int J Radiat Oncol Biol Phys, 2005, 62(5): 1345-1350. ［4］ Wang BH, Cao WM, Yu J, et al. Gemcitabinebased concurrent chemoradiotherapy versus chemotherapy alone in patients with locally advanced pancreatic cancer［J］. Asian Pac J Cancer Prev, 2012, 13(5): 2129-2132. ［5］ Loehrer PJ Sr, Feng Y, Cardenes H, et al. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial［J］. J Clin Oncol, 2011, 29(31): 4105-4112. ［6］ Leone F, Gatti M, Massucco P, et al. Induction gemcitabine and oxaliplatin therapy followed by a twiceweekly infusion of gemcitabine and concurrent externalbeam radiation for neoadjuvant treatment of locally advanced pancreatic cancer: a single institutional experience［J］. Cancer, 2013, 119(2): 277-284. ［7］ Kim JS, Lim JH, Kim JH, et al. Phase Ⅱ clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer［J］. Cancer Chemother Pharmacol, 2012, 70(3): 381-389. ［8］ Trakul N, Koong AC, Maxim PG, et al. Modern radiation therapy techniques for pancreatic cancer［J］. Gastroenterol Clin North Am, 2012, 41(1): 223-235. ［9］ Abelson JA, Murphy JD, Minn AY, et al. Intensitymodulated radiotherapy for pancreatic adenocarcinoma［J］. Int J Radiat Oncol Biol Phys, 2012, 82(4): e595-601. ［10］ Pipas JM, Zaki BI, McGowan MM, et al. Neoadjuvant cetuximab, twiceweekly gemcitabine, and intensitymodulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma［J］. Ann oncol, 2012, 23(11): 2820-2827. ［11］ Combs SE, Habermehl D, Kessel K, et al. Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer. Outcome analysis and comparison with a 3Dtreated patient cohort［J］. Strahlenther Onkol, 2013, 189(9): 738-744. ［12］ Chuong MD, Springett GM, Freilich JM, et al. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated［J］. Int J Radiat Oncol Biol Phys, 2013, 86(3): 516-522. ［13］ Polistina F, Costantin G, Casamassima F, et al. Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration［J］. Ann Surg Oncol, 2010, 17(8): 2092-2101. ［14］ Rwigema JC, Parikh SD, Heron DE, et al. Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas［J］. Am J Clin Oncol, 2011, 34(1): 63-69. ［15］ Wang J, Jiang Y, Li J, et al. Intraoperative ultrasoundguided iodine125 seed implantation for unresectable pancreatic carcinoma［J］. J Exp Clin Cancer Res, 2009, 28:88. ［16］ Diaz Beveridge R, Alcolea V, Aparicio J, et al. Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical practice［J］. JOP, 2014,15(1): 19-24. ［17］ Aparicio J, GarcíaMora C, Martín M, et al. A phase Ⅰ, dosefinding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Espaol Multidisciplinario en Cáncer Digestivo (GEMCAD) study［J］. PLoS One, 2014, 9(1): e82209. ［18］ Cetin V, Piperdi B, Bathini V, et al. A phase Ⅱ trial of cetuximab, gemcitabine, 5Fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma［J］. Gastrointest Cancer Res: GCR, 2013, 6 (4 Suppl 1): S2-9. ［19］ Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nabpaclitaxel plus gemcitabine［J］. N Engl J Med, 2013, 369(18): 1691-1703.

[1]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[4]	Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156.
[5]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174.
[6]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42.
[7]	Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552.
[8]	Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367.
[9]	Lyu Lu, Sun Pengfei.Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376.
[10]	Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association.Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy （2023 version）[J]. Journal of International Oncology, 2023, 50(4): 193-201.
[11]	Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng.Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance[J]. Journal of International Oncology, 2023, 50(4): 227-230.
[12]	Shi Xaioqi, Wang Hongyan.Research progress on the interaction between gut microbiota and radiation enteritis[J]. Journal of International Oncology, 2023, 50(4): 244-247.
[13]	Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun.Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases[J]. Journal of International Oncology, 2023, 50(3): 138-143.
[14]	Huang Huayu, Gong Hongyun, Song Qibin.Influencing factors of pneumonitis in the period of thoracic radiotherapy combined with immunotherapy[J]. Journal of International Oncology, 2023, 50(2): 102-106.
[15]	Cao Xiaohui, Yu Hong, Li Wanhu.Application of CT-based radiomics analysis in predicting and identifying of treatment-associated pneumonitis[J]. Journal of International Oncology, 2023, 50(2): 107-111.

Radiotherapy of locally advanced pancreatic cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments